| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |